Flow Cytometry is Estimated to Witness High Growth
Flow Cytometry is Estimated to Witness High Growth
The global flow cytometry market is estimated to be valued at US$ 6280.32 Mn in 2023 and is expected to exhibit a CAGR of 18% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Flow cytometry is a widely used technique in various industries such as academic & research, biotechnology and pharmaceutical, clinical, etc. for detection and quantitation of physical and chemical characteristics of biological particles like cells and chromosomes. Flow cytometry allows simultaneous multi-parametric analysis of physical and chemical characteristics of microscopic particles suspended in a moving fluid stream on the basis of scattered light fluctuations. The technology provides various advantages like high-speed analysis of thousands of particles per second, multi-parametric analysis with high resolution and sensitivity, and simultaneous measurement of more than 15 parameters in a single run. The growing demand for diagnosis of various diseases and the need for early detection is boosting the flow cytometry market.

Market Opportunity:

Single cell analysis offers exciting potential for precise interpretation of cellular heterogeneity and functions at single cell resolution. Flow cytometry allows high-throughput analysis of thousands of single cells per second, which enables analysis of rare cell populations. Advancements in single cell analysis technologies based on fluorescence-activated cell sorting are expected to propel the flow cytometry market growth during the forecast period. Single cell analysis finds wide applications in cancer research, immunology and stem cell research. Thus, increasing focus on single cell analysis for deeper understanding of complex cellular systems is anticipated to present lucrative growth opportunities for players in the flow cytometry market.

Porter's Analysis

Threat of new entrants: The market sees high capital investments and the need for technical expertise as barriers for new companies. However, growth opportunities exist for specialized products.

Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of different product options from global suppliers. However, switching costs are moderate.

Bargaining power of suppliers: Key raw material suppliers have low to moderate bargaining power due to the availability of substitutes and less differentiation in materials.

Threat of new substitutes: Threat from substitutes is low as flow cytometry caters to specialized applications in research and diagnostics with no close substitutes.

Competitive rivalry: The market sees intense competition among major players and price wars. Differentiation is through expanded product portfolios and service offerings.

SWOT Analysis

Strengths: Growing diagnostic and research applications. Technology advancements enabling high throughput and multiparametric analysis.

Weaknesses: High installation and maintenance costs. Requirement of trained professionals limiting adoption.

Opportunities: Emerging economies provide high growth potential. Point of care applications open new avenues.

Threats: Stringent regulations delay product approvals. Reimbursement issues in developing nations.

Key Takeaways

The Global Flow Cytometry Market Demand is expected to witness high growth due to rising cancer cases and increasing stem cell research activities.

Regional Analysis: North America dominated the market in 2024 due to presence of global players and established healthcare infrastructure. However, Asia Pacific is poised to register the fastest growth over the forecast period supported by growing biomedical industry, favorable policies and low manufacturing costs.

Key players operating in the flow cytometry market are Google Inc., Apple Inc., Rethink Robotics, BAE Systems, Narrative Science Inc., Creative Virtual Ltd., Microsoft Corporation, Digital Reasoning Systems, Inc., and IBM Corporation. The major players are focusing on new product launches and expanding their geographical presence through acquisitions and collaborations with regional players. For instance, in 2022, Apple Inc. acquired Flow Cytometry start-up Boundless Bio to enhance its healthcare portfolio.

 

Explore more information on this topic, Please visit -

https://www.ukwebwire.com/flow-cytometry-market-share-and-trends-analysis/ 

Explore more trending article related this topic -

https://allmeaninginhindi.com/exploring-the-vital-world-of-intravenous-solutions-for-health-and-healing/

disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations